Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: james who wrote (1304)	12/1/1997 12:50:00 AM
From: michael redmond	Read Replies (1) \| Respond to of 4676

James et all...Jim McCamant from Medical Tech Stock Letter to be on CNBC "Squawk Box" today (12.1) 5a to 7a PST. He loves ISIS. Should be good for a pop...Mike

To: james who wrote (1304)	12/1/1997 2:29:00 AM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 4676

James: You are welcome to actively participate on this thread. >><Definitely, I do not agree with many posts on ENMD and SUGN thread,>. That is great!!!!!!!!!! I am the only regular recently on SUGN thread. This must includes most of my posts.<< Partially is related to your posts, but majority of my address is to early posts which only hype and do not give in-depth analysis of issue discussed. Posting the links to Medline abstracts and PTO patents, without explanation (partial info, abstract show only bride side of the coin) of the reasons to bring the articles, is confusing to majority of the reader, IMO. I do thank you on you biology training and quality of the discussion related to field. Also, one bigger misunderstanding is in relation to Angiostatin TM. BLSI received notice on allowance for Troponin I (Axogenesis Factor 1) not Angiostatin. This is different protein and is active in CNS oxon formation. Angiostatin protein, Patent 5,639,725, is exclusively licensed to ENMD and is field of ENMD collaboration with BMY. More on SUGN thread. mz